PNL5 ASSESSING ABSOLUTE REDUCTIONS IN CLINICAL EFFECT- A MODEL FOR COMPARING THE COST-EFFECTIVENESS OF DISEASE MODIFYING DRUGS (DMDS) UTILIZED IN THE TREATMENT OF MULTIPLE SCLEROSIS (MS)
May 1, 2006, 00:00
10.1016/S1098-3015(10)64554-8
https://www.valueinhealthjournal.com/article/S1098-3015(10)64554-8/fulltext
Title :
PNL5 ASSESSING ABSOLUTE REDUCTIONS IN CLINICAL EFFECT- A MODEL FOR COMPARING THE COST-EFFECTIVENESS OF DISEASE MODIFYING DRUGS (DMDS) UTILIZED IN THE TREATMENT OF MULTIPLE SCLEROSIS (MS)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)64554-8&doi=10.1016/S1098-3015(10)64554-8
First page :
Section Title :
Open access? :
No
Section Order :
474